Earnings History Data for Spruce Biosciences (SPRB) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Spruce Biosciences

Spruce Biosciences Inc. is a biopharmaceutical company. It focuses on developing and commercializing novel therapies for rare endocrine disorders. The company develops tildacerfont, an non-steroidal therapy which are in clinical stage. Spruce Biosciences Inc. is based in Daly City, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
13-03-2024	AH		SPRB	Spruce Biosciences	208.00	-0.23	-0.41	0.00	Spruce Biosciences reports FY results [3/13/2024 5:13 PM]	0.8050	-4.38 (-84.49%)	1.15	-4.04 (-77.84%)	0.78 - 5.95	21,409,406	780,000	2,908,381
Spruce Biosciences reports FY results [3/13/2024 5:13 PM] Spruce Biosciences stock craters 75% on failed Phase 2 study [3/13/2024 5:39 PM]
13-11-2023	AH		SPRB	Spruce Biosciences	43.00	-0.30	-0.34	0.00	Spruce Biosciences GAAP EPS of -$0.30 beats by $0.05 [11/13/2023 5:27 PM]	1.02	-0.06 (-5.37%)	0.0	0.0 (0.00%)	0.95 - 3.57	225,287	200,000	0
Spruce Biosciences GAAP EPS of -$0.30 beats by $0.05 [11/13/2023 5:27 PM]
14-08-2023	AH		SPRB	Spruce Biosciences	90.00	-0.32	-0.37	0.00	Spruce Biosciences GAAP EPS of -$0.32, revenue of $2.2M [8/14/2023 5:18 PM]	2.17	-0.02 (-0.91%)	0.0	0.0 (0.00%)	0.95 - 3.57	80,787	60,000	0
Spruce Biosciences GAAP EPS of -$0.32, revenue of $2.2M [8/14/2023 5:18 PM]
16-03-2023	AH	4:00 PM ET (Mar 16)	SPRB	Spruce Biosciences	55.00	-0.47	-0.55	0.00	Spruce Biosciences GAAP EPS of -$1.96 beats by $0.05 [3/16/2023 4:50 PM]	2.30	0.01 (0.44%)	2.26	-0.03 (-1.31%)	0.95 - 3.57	65,658	140,000	5,907
Spruce Biosciences GAAP EPS of -$1.96 beats by $0.05 [3/16/2023 4:50 PM]
10-11-2022	AH		SPRB	Spruce Biosciences	25.00	-0.48	-0.54	0.00	Spruce Biosciences GAAP EPS of -$0.48 beats by $0.06 [11/10/2022 11:34 PM]	1.10	0.05 (4.76%)	0.0	0.0 (0.00%)	0.96 - 5.80	40,350	40,000	0
Spruce Biosciences GAAP EPS of -$0.48 beats by $0.06 [11/10/2022 11:34 PM] Spruce Biosciences Reports Third Quarter 2022 Financial Results and Provides Corporate Updates [Nov-10-22 04:01PM]
14-03-2022	AH		SPRB	Spruce Biosciences	48.00	-0.39	-0.57	0.00	Spruce Biosciences GAAP EPS of -$1.81 [3/14/2022 5:52 PM]	1.86	-0.02 (-1.06%)	1.88	0.0 (0.00%)	0.0 - 0.0	80,562	0	100
Spruce Biosciences hires new Chief Medical Officer [3/14/2022 4:11 PM] Spruce Biosciences GAAP EPS of -$1.81 [3/14/2022 5:52 PM] Spruce Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Updates [Mar-14-22 04:05PM] Spruce Biosciences Appoints Will Charlton, M.D., M.A.S., as Chief Medical Officer [Mar-14-22 04:01PM]
15-11-2021	AH		SPRB	Spruce Biosciences	103.00	-0.49	-0.57	0.00	Spruce Biosciences EPS beats by $0.08 [11/15/2021 4:55 PM]	3.04	-1.34 (-30.67%)	4.24	-0.14 (-3.30%)	3.03 - 35.60	1,217,930	100,000	2,731
Spruce Biosciences EPS beats by $0.08 [11/15/2021 4:55 PM] Spruce biosciences appoints Mike Grey as interim CEO [11/16/2021 10:13 AM] Spruce Biosciences Reports Third Quarter 2021 Financial Results and Provides Corporate Updates [Nov-15-21 04:05PM] Spruce Biosciences Appoints Mike Grey as Interim CEO [Nov-15-21 04:01PM]
10-08-2021	AH	4:05 PM ET (Aug 10)	SPRB	Spruce Biosciences, Inc.	198.00	-0.50	-0.45	0.00	Spruce Biosciences EPS misses by $0.07 [8/10/2021 5:22 PM]	7.85	-0.06 (-0.76%)	0.0	0.0 (0.00%)	7.83 - 35.60	36,249	40,000	0
Spruce Biosciences EPS misses by $0.07 [8/10/2021 5:22 PM] Spruce Biosciences Reports Second Quarter 2021 Financial Results and Provides Corporate Updates [Aug-10-21 04:05PM] Why Earnings Season Could Be Great for Spruce Biosciences (SPRB) [Aug-10-21 11:59AM] Spruce Biosciences Expands Tildacerfont Portfolio with Potential Treatment for Polycystic Ovary Syndrome [Aug-11-21 08:55AM]
12-05-2021	AH		SPRB	Spruce Biosciences, Inc.	345.00	-0.42	-0.44	0.00	Spruce Biosciences EPS beats by $0.02 [5/12/2021 4:53 PM]	14.97	0.21 (1.42%)	14.76	0.0 (0.00%)	14.18 - 35.60	63,264	90,000	220
Spruce Biosciences EPS beats by $0.02 [5/12/2021 4:53 PM] Spruce Biosciences Reports First Quarter 2021 Financial Results and Provides Corporate Updates [May-12-21 04:05PM] Spruce Biosciences to Participate in the RBC Capital Markets Global Healthcare Conference [May-13-21 04:05PM]
22-03-2021	AH		SPRB	Spruce Biosciences, Inc.	409.00	-0.39	-0.60	0.00	Spruce Biosciences EPS beats by $0.34 [3/22/2021 4:29 PM]	16.97	-1.00 (-5.56%)	0.0	0.0 (0.00%)	15.12 - 35.60	37,388	110,000	0
Spruce Biosciences EPS beats by $0.34 [3/22/2021 4:29 PM] Spruce Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Recent Corporate Updates [Mar-22-21 04:05PM]